Veräjänkorva Esko, Rautio Riitta, Giordano Salvatore, Koskivuo Ilkka, Savolainen Otto
Department of Surgery, Division of Plastic Surgery, Turku University Hospital, Turku, Finland.
Department of Radiology, Turku University Hospital, Turku, Finland.
Plast Surg Int. 2016;2016:2809152. doi: 10.1155/2016/2809152. Epub 2016 Dec 15.
malformations are a vast group of congenital malformations that are present at birth. These malformations can cause pain, pressure, and cosmetic annoyance as well as downturn growth and development in a child in the case of . Sclerotherapy has become an important tool in the treatment of vascular malformations. However, little is known about the success rate of sclerotherapy. . In this study, the efficiency of sclerotherapy in the treatment of vascular anomalies was investigated retrospectively in 63 patients treated in Turku University Hospital between 2003 and 2013. . Out of the 63 patients investigated, 83% (53) had venous malformations (VMs) and 9% (5) were defined as having arteriovenous malformations (AVMs). Patients with a VM were operated on, in 14% (8) out of all VM cases. Hence 86% (45) of patients with a VM received adequate help to their symptoms solely from sclerotherapy. The duration of treatment for the 14% of the VM patients that needed a surgical procedure was prolonged by 7-9 months, that is, by 41%. . Sclerotherapy is an effective method in the treatment of VMs with a satisfactory clinical response in patients symptoms in 84% of cases.
血管畸形是一大类出生时就存在的先天性畸形。这些畸形可引起疼痛、压迫感、外观困扰，以及在儿童中导致生长发育迟缓。硬化疗法已成为治疗血管畸形的重要手段。然而，关于硬化疗法的成功率知之甚少。在本研究中，对2003年至2013年在图尔库大学医院接受治疗的63例患者进行回顾性研究，以调查硬化疗法治疗血管异常的疗效。在63例被调查患者中，83%（53例）患有静脉畸形（VMs），9%（5例）被定义为患有动静脉畸形（AVMs）。VM患者中，14%（8例）接受了手术治疗。因此，86%（45例）的VM患者仅通过硬化疗法就使症状得到了充分缓解。14%需要手术治疗的VM患者的治疗时间延长了7至9个月，即延长了41%。硬化疗法是治疗VMs的有效方法，84%的病例患者症状有令人满意的临床反应。
